Skip to content

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05228509
Acronym
Portalflow
Enrollment
75
Registered
2022-02-08
Start date
2021-05-04
Completion date
2024-12-30
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis Portal

Brief summary

Portal vein flow velocity as screening tool for prediction of oesophageal varices in cirrhotic patient without upper endoscopy

Detailed description

Portal vein flow velocity as screening tool for prediction of oesophageal varices in cirrhotic patient without upper endoscopy with its high cost & complications Using portal vein flow velocity and the relation between it & presence of oesophageal varices in cirrhotic patient & its efficacy as a primary tool for these cases

Interventions

None listed

Sponsors

Peter atef
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL

Inclusion criteria

* cirrhotic patients with oesophageal varices * cirrhotic patients without oesophageal varices

Exclusion criteria

* Patients with hepato-cellular carcinomas \[HCCs\], portal vein thrombosis, hepatic encephalopathy. * Patients with positive HCV antibody, but without liver cirrhosis diagnostic criteria

Design outcomes

Primary

MeasureTime frameDescription
Using upper GIT endoscopy to detect the presence or absence of oesophageal varices3 yearsNon-invasive screening tool for esophageal varices: Aspartate aminotransferase-to-platelet ratio index (APRI) ... Doppler ultrasound of portal system Elastography both of liver and spleen... -Research outcome measures: a. Primary (main): Using upper GIT endoscopy to detect the presence or absence of oesophageal varices, and to detect the best and most available non- invasive predictor for it.

Countries

Egypt

Contacts

Primary ContactPeter At Rizk
Peteratef662@gmail.com01553529181
Backup ContactAtef Mu Rizk
Peteratef669@gmail.com01003938077

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026